apobank
play

apoBank The Leading Bank in the German Healthcare Sector. August - PowerPoint PPT Presentation

apoBank The Leading Bank in the German Healthcare Sector. August 2018. Investor-Update. 1 Agenda 1 apoBank profile. 2 Income statement, financial and risk position as at 30 June 2018. 3 Funding. Investor-Update. 2 apoBank At a


  1. apoBank – The Leading Bank in the German Healthcare Sector. August 2018. Investor-Update. 1

  2. Agenda 1 apoBank profile. 2 Income statement, financial and risk position as at 30 June 2018. 3 Funding. Investor-Update. 2

  3. apoBank – At a glance. Close to our customers. Largest cooperative bank. 84 Our 2,532 employees at 84 locations cater to the We are member of the National Association of needs of our customers. Germen cooperative Banks (BVR) and part of the BVR deposit insurance system. Our mission. A captivating idea. We promote our members, in particluar professionals 448,300 customers, of which are 112,210 in the healthcare sector, and their organisations as members of the bank, are convinced of our well as corporations active in the healthcare sector.. mission. Rating of Total Net profit New lending Tier 1 apoBank: ratio: assets: after tax: business: AA- 18.7 % 44.1 31.4 3.6 S&P bn Euro mn Euro bn Euro Stand Juni 2018 Investor-Update. 3

  4. The healthcare sector is changing. digitalisation cooperation supply across sectors employment industrialisation internationalisation capitalisation Investor-Update. 4

  5. Larger units with increasing importance. 51,831 51,679 51,240 50,479 +5% 49,208 20,044 19,877 19,174 19,043 18,826 -6% 15,362 13,826 12,955 11,060 +85% 8,326 2,490 2,073 2,156 1,938 1,654 +51% 2010 2012 2014 2015 2016 Doctors in professional associations Doctors in medical care centres Number of professional associations Number of medical care centres Source: KBV 2017 Investor-Update. 5

  6. Accelerator digitalisation.  Structures and opportunities of health cares services change fundamentally  Large volumes of medical data change information processes and needs New E-Health-Law leads to  systematic digitalisation in the healthcare market  Large health care companies, online and tec-companies betting on economic potential of the digital healthcare market Investor-Update. 6

  7. apoBank’s strategy at a glance. ☞ ! A P O B A N K ’ S C H A L L E N G E S M E A S U R E S C O M P E T I T I V E A D V A N T A G E S  Decline in new start-up numbers  Programme Exi70+  Generation Y: claim to be  Exi-eco system  Market and customer know- independent, flexibility, feminisation  Close networking with professional how  Trend towards being employed associations  Specialist bank and  Trend towards cooperations  Intensifying investment business for member of the healthcare customers  New forms of medical services sector  Intensified support of employed  New competitors  Market leader in healthcare professionals and medical  Change in customer behaviour financing start-ups students (digitalisation)  Strong brand  Moderate expansion of corporate  Growing industrialisation  Member of the client business  Dissolution of separation between cooperative Group  Implementation of multi channel inpatient and outpatient care: growth strategy: digital-face/to/face services potential with healthcare companies  More co operations with external partners in cooperative group  Expansion of value added services (seminars etc.) Investor-Update. 7

  8. Strong brand in the healthcare sector. T HE BANK FOR HEALTHCARE A WARDS FOR ITS ASSET MANAGEMENT A WARDS AS EMPLOYER PROFESSIONALS cooperative members physicians clearence centres healthcare pharmacists organisations infrastructure specialised tax institutions counselors Investor-Update. 8

  9. Agenda 1 apoBank profile. 2 Income statement, financial and risk position as at 30 June 2018. 3 Funding. Investor-Update. 9

  10. Income statement for first half 2018. 1.1.- 1.1.- Euro million ∆ in % 30.6.2017 30.6.2018 Net interest income 325.3 339.7 4.4 Net commission income 88.0 87.1 -1.0 General administrative expenses -258.4 -288.1 11.5 Operating profit before risk provisioning 158.5 134.2 -15.3 Risk provisioning from the operating business 6.8 -2.8 - Risk provisioning with reserve character -87.6 -78.1 -10.8 Operating result 77.7 53.3 -31.4 Taxes -46.9 -21.9 -53.3 Net profit after tax 30.9 31.4 1.8 Investor-Update. 10

  11. Good regulatory capital position. Regulatory capital, Euro million Regulatory capital ratios 26.1% 26.1% 2,567 25.0% 2,528 2,465 2,411 2,340 235 21.8% 275 324 20.6% 383 450 22.6% 22.0% 1,166 20.2% 1,100 19.5% 1,017 18.7% 936 839 1,154 1,167 1,092 1,124 1,051 2014 2015 2016 2017 6/2018 2014 2015 2016 2017 6/2018 Supplementary capital Cooperative shares Total capital Common equity tier 1 ratio Reserves and other Total capital Risk weighted assets, Euro billion 12.5 11.6 9.4 9.5 9.2 2014 2015 2016 2017 6/2018 Investor-Update. 11

  12. RWA increase further in line with rising lending volumes. vs. 31.12.2017 RWA. Euro million 908 -28 934 378 347 128 -6 87 12,492 11,292 1,200 6,693 2,847 654 294 804 RWA as at Market price Credit risk Retail Corporates Institutions Particpations Other, incl. 30.6.2018 and operational states risk / CVA Investor-Update. 12

  13. Development of selected key figures. Members, thds Customer deposits and loans, Customers, thds Euro billion 448 112 33.4 111 436 110 32.0 108 106 416 29.5 397 382 27.9 27.0 27.1 26.0 25.8 23.6 21.7 2014 2015 2016 2017 6/2018 2014 2015 2016 2017 6/2018 2014 2015 2016 2017 6/2018 Deposits Loans Investor-Update. 13

  14. Steady portfolio growth. Retail business, Euro billion  Brisk new business with retail as well as corporate clients 37.2 36.2 33.8 32.3 31.2 29.7 28.7  Financial instruments portfolio with 26.8 25.9 25.2 focus on LCR compliant securities and money market products 2014 2015 2016 2017 6/2018 Credit line Utilitsation Corporate business, Euro billion 6.7 6.3 5.4 4.7 4.6 4.3 4.0 3.6 3.1 2.8 2014 2015 2016 2017 6/2018 Volume of financial instruments, Euro billion 7.3 7.1 6.8 6.3 6.2 2014 2015 2016 2017 6/2018 Investor-Update. 14

  15. Portfolio with good creditworthiness.  Stable rating profile in good rating classes Retail business* 46.6% 42.1% 34.5% 29.9% 16.6% 15.4% 7.2% 5.3% 1.4% 1.3% AAA-AA A BBB BB-C D Corporate business* 50.8% 47.8% 27.8% 26.0% 14.5% 13.7% 9.6% 8.1% 1.2% 0% AAA-AA A BBB BB-C D Financial instruments* 89.0% 86.1% 9.3% 11.4% 1.3% 1.2% 0.7% 0% 0,0% 0% 0% 0.9% AAA-AA A BBB BB-C D ohne Rating 31.12.2017 30.06.2018 *Mapping of internal apoBank rating classes (BVR-Masterskala) to external rating classes based on underlying default probabilities Investor-Update. 15

  16. Regulatory data. 31.12. 30.6. EU-average in percent 2017 2018 (31.3.2018) 5,1 Tier 1 capital in relation to overall risk, minimum Leverage ratio 5,2 5,0 of 3% as of 2020 onwards, expectedly Highly liquid assets in relation to liquidity outflow Liquidity coverage ratio, LCR 132 137 147 within the next 30 days, minimum of 100% as of 1.1.2018 Stable funding means available in relation to Net stable funding ratio, NSFR 108 111 - necessary funding means, minimum of 100% as of 2020, expectedly Asset encumbrance ratio 32,8 33,0 28,7 Share of pledged assets 3,9 Share of non performing loans in relation to total Non performing loans ratio, NPL 1,5 1,3 credit volume 46,3 Share of provisioned loans in relation to non Coverage ratio 36,6 35,1 performing loans 2,5 Share of restructured loans in relation to total Forbearance ratio 1,4 1,3 credit volume Investor-Update. 16

  17. Agenda 1 apoBank profile. 2 Income statement, financial and risk position as at 30 June 2018. 3 Funding. Investor-Update. 17

  18. Very good credit assessments. S&P Fitch Ratings (group rating) Counterparty credit rating AA- Issuer Default Rating longterm AA- Short-term debt A-1+ Issuer Default Rating short-term F1+ Pfandbriefrating (covered bonds) AAA Outlook stable Senior unsecured (preferred) AA- Senior subordinated (non preferred) A+ Outlook stable Investor-Update. 18

  19. Broad product range. P RODUCT DETAILS P RODUCTS T ARGETS  Congruent refinancing of assets  Commercial paper  Fixed coupon ensuring liquidity at all times  Step up / step down  Promissory notes  Flexible funding activities by  Registered bonds  Variable coupon extending the product range  With cap and floor (result: senior  Registered covered bonds  Expanding investor base preferred)  Benchmark issues supporting increasing capital  Callable market funding  Single callable D E B T I S S U A N C E P R O G R A M M E  Perception in the capital markets as  Multi callable ( D I P ) : reliable and constant issuer  apoObligationen (bearer bonds for  Rising share of covered bonds in retail clients) long-term capital market funding  Bearer bonds  Covered bonds Investor-Update. 19

  20. Highly diversified customer base. R ETAIL , ORGANISATIONS , I NVESTORS P ARTNER BANKS CORPORATE CLIENTS  > 300 institutional investors  > 50 partner banks and capital  448,000 retail clients, organisations market participants (via dealer and corporate clients  > 200 investors from cooperative banks)  Stable base of less volatile banking group customer deposits growing steadily  Refinancing via public loans from KfW Bankengruppe and various other promotional banks Investor-Update. 20

Recommend


More recommend